Source: AAHA
The 2026 Diabetes Management Guidelines for Cats from the American Animal Hospital Association (AAHA) highlight major advances in understanding and treating feline diabetes. Recognizing that diabetes differs significantly between cats and dogs, AAHA created separate, species-specific guidelines. A key shift is the growing preference for SGLT2 inhibitors as a first-line treatment, replacing insulin in many cases due to their safety and effectiveness. Increased clinical experience has also allowed experts to expand recommendations and clarify when insulin is still appropriate.
The guidelines emphasize a broader approach to care, including managing complications like diabetic ketoacidosis and supporting general practitioners in stabilizing patients when advanced care isn’t accessible. They also provide updated advice on identifying risk factors, monitoring patients, and educating pet owners. Overall, the new guidelines reflect evolving knowledge and aim to simplify and improve outcomes in feline diabetes management.